CYP 0.00% 21.0¢ cynata therapeutics limited

Ann: Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD, page-21

  1. 80 Posts.
    lightbulb Created with Sketch. 53
    Totally agree. That is why a positive 28 readout is so critical, it will confirm that CYP has a commercial product that is safe. Hypothetically, if CYP decides to be a raw-product supplier to Bio-pharma, it would not have to fund any further FDA trials. There are many options open to the company to have early revenue streams. Fuji is just one of many revenue models.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $37.91M
Open High Low Value Volume
21.0¢ 21.0¢ 21.0¢ $1K 4.76K

Buyers (Bids)

No. Vol. Price($)
1 7339 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 9000 1
View Market Depth
Last trade - 11.02am 26/08/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.